XAIR – beyond air, inc. (US:NASDAQ)
Stock Stats
News
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting [Yahoo! Finance]
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting
Beyond Air, Inc. (NASDAQ: XAIR) had its price target lowered by analysts at Truist Financial Co. from $10.00 to $8.00. They now have a "buy" rating on the stock.
Beyond Air (XAIR) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
Form 8-K Beyond Air, Inc. For: Mar 20
Form 424B5 Beyond Air, Inc.
Form 4 Beyond Air, Inc. For: Mar 20 Filed by: Forbes William P
Form 4 Beyond Air, Inc. For: Mar 20 Filed by: Larson Douglas Quinton
Form 4 Beyond Air, Inc. For: Mar 20 Filed by: Lucera Erick
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.